- A long-established Médecins Sans Frontières project providing basic healthcare to highly vulnerable communities in northern and eastern Rakhine state was suspended by the authorities in February and resumed only in mid-December.
- Prior to the suspension, Médecins Sans Frontières provided medical services in 24 camps for displaced people and in isolated villages across Rakhine. From June, Médecins Sans Frontières was able to provide medical staff to facilities managed by the Ministry of Health in Rakhine, and supplied resources such as vehicles and medical equipment to the Ministry of Health Rapid Response Teams in Sittwe and Pauktaw townships.
- HIV patients previously under Médecins Sans Frontières care were also supported.
- Not all of Médecins Sans Frontières' project activities had restarted by the end of 2014.
HIV and tuberculosis (TB)
- Working in collaboration with the Ministry of Health, Médecins Sans Frontières remains a key provider of HIV/AIDS and TB care in Myanmar, supplying antiretrovirals (ARVs) to more than half of the people undergoing treatment.
- Médecins Sans Frontières treats patients co-infected with TB and HIV through integrated programmes in Shan and Kachin states, as well as in Yangon and Dawei in Tanintharyi region.
- These programmes also offer treatment for sexually transmitted infections, health education, psychological and social support and prevention of mother-to-child transmission of HIV.
- In November, Médecins Sans Frontières inaugurated its newly renovated clinic in Insein Township in Yangon. The largest HIV/AIDS and TB clinic in Myanmar, it is currently treating approximately 10,000 HIV/TB patients.
- In late 2014, Médecins Sans Frontières also started supporting three HIV testing and counselling centres in Dawei and the surrounding area, focusing particularly on harder-to-reach groups, such as sex workers, migrant workers and men who have sex with men. Médecins Sans Frontières counsellors also conduct support groups within these communities.
- A landmark development occurred in 2014 for the treatment of cytomegalovirus (CMV) retinitis, an HIV-related infection that causes blindness. Following many years of price negotiations with a pharmaceutical company, Médecins Sans Frontières began providing its patients in Dawei with valganciclovir, a single daily pill taken orally. Although it has been available in high-income countries since 2001, this is the first time Médecins Sans Frontières has been able to use the drug; patients previously had to endure uncomfortable injections directly into the eye.
For the latest news on where we work: http://activityreport.msf.org/
Médecins Sans Frontières has worked in the country since 1992 and at the end of 2014, Médecins Sans Frontières had 1,146 staff in Myanmar.